18473714

Source:http://linkedlifedata.com/resource/pubmed/id/18473714

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists.
Subject	Predicate	Object	Context
pubmed-article:18473714	rdf:type	pubmed:Citation	lld:pubmed
pubmed-article:18473714	lifeskim:mentions	umls-concept:C0007226	lld:lifeskim
pubmed-article:18473714	lifeskim:mentions	umls-concept:C0035649	lld:lifeskim
pubmed-article:18473714	lifeskim:mentions	umls-concept:C0082608	lld:lifeskim
pubmed-article:18473714	lifeskim:mentions	umls-concept:C1524063	lld:lifeskim
pubmed-article:18473714	pubmed:issue	8	lld:pubmed
pubmed-article:18473714	pubmed:dateCreated	2008-5-13	lld:pubmed
pubmed-article:18473714	pubmed:abstractText	Fluvastatin was the first synthetic 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor (statin) to be developed and is used in the management of dyslipidaemia in primary and secondary prevention of cardiovascular disease.	lld:pubmed
pubmed-article:18473714	pubmed:language	eng	lld:pubmed
pubmed-article:18473714	pubmed:journal	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:18473714	pubmed:citationSubset	IM	lld:pubmed
pubmed-article:18473714	pubmed:chemical	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:18473714	pubmed:chemical	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:18473714	pubmed:chemical	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:18473714	pubmed:chemical	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:18473714	pubmed:chemical	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:18473714	pubmed:status	MEDLINE	lld:pubmed
pubmed-article:18473714	pubmed:month	Jun	lld:pubmed
pubmed-article:18473714	pubmed:issn	1744-7666	lld:pubmed
pubmed-article:18473714	pubmed:author	pubmed-author:McDonaldKenne...	lld:pubmed
pubmed-article:18473714	pubmed:author	pubmed-author:JardineAlan...	lld:pubmed
pubmed-article:18473714	pubmed:issnType	Electronic	lld:pubmed
pubmed-article:18473714	pubmed:volume	9	lld:pubmed
pubmed-article:18473714	pubmed:owner	NLM	lld:pubmed
pubmed-article:18473714	pubmed:authorsComplete	Y	lld:pubmed
pubmed-article:18473714	pubmed:pagination	1407-14	lld:pubmed
pubmed-article:18473714	pubmed:meshHeading	pubmed-meshheading:18473714...	lld:pubmed
pubmed-article:18473714	pubmed:meshHeading	pubmed-meshheading:18473714...	lld:pubmed
pubmed-article:18473714	pubmed:meshHeading	pubmed-meshheading:18473714...	lld:pubmed
pubmed-article:18473714	pubmed:meshHeading	pubmed-meshheading:18473714...	lld:pubmed
pubmed-article:18473714	pubmed:meshHeading	pubmed-meshheading:18473714...	lld:pubmed
pubmed-article:18473714	pubmed:meshHeading	pubmed-meshheading:18473714...	lld:pubmed
pubmed-article:18473714	pubmed:meshHeading	pubmed-meshheading:18473714...	lld:pubmed
pubmed-article:18473714	pubmed:meshHeading	pubmed-meshheading:18473714...	lld:pubmed
pubmed-article:18473714	pubmed:meshHeading	pubmed-meshheading:18473714...	lld:pubmed
pubmed-article:18473714	pubmed:meshHeading	pubmed-meshheading:18473714...	lld:pubmed
pubmed-article:18473714	pubmed:year	2008	lld:pubmed
pubmed-article:18473714	pubmed:articleTitle	The use of fluvastatin in cardiovascular risk management.	lld:pubmed
pubmed-article:18473714	pubmed:affiliation	University of Glasgow, BHF Glasgow Cardiovascular Research Centre, 126 University Place, Glasgow G12 8TA, UK.	lld:pubmed
pubmed-article:18473714	pubmed:publicationType	Journal Article	lld:pubmed
pubmed-article:18473714	pubmed:publicationType	Comparative Study	lld:pubmed
pubmed-article:18473714	pubmed:publicationType	Review	lld:pubmed